BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update

  Precision BioSciences, Inc. announced financial results for the third quarter ended September 30, 2023 and provided a business update.

  November 7, 2023

   · 

  18 min read
• Drug Development

  Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease

  Cognition Therapeutics, Inc. today announced that the last participant was randomized in the Phase 2 SHINE study ( NCT03507790 ) of CT1812, the company’s lead candidate for the treatment of age-related neurodegenerative diseases of the CNS and retina.

  November 7, 2023

   · 

  7 min read
• Business

  Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

  Sensei Biotherapeutics, Inc. today reported financial results for the third quarter ended September 30, 2023, and provided recent business updates.

  November 7, 2023

   · 

  11 min read
• Business

  XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value

  XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, reported its third quarter 2023 financial results.

  November 7, 2023

   · 

  12 min read
• Business

  Syros to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

  Syros Pharmaceuticals today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, November 14, 2023 to report its third quarter 2023 financial results and provide a corporate update.

  November 7, 2023

   · 

  1 min read
• Business

  Surgery Partners, Inc. Announces Third Quarter 2023 Results

  Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  22 min read
• Pharm Country

  Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit

  Ocugen, Inc. today announced that Arun Upadhyay, PhD, Ocugen’s Chief Scientific Officer, Head of Research, Development and Medical, will be among the featured speakers at the 4th Annual Dry AMD Therapeutic Development Summit, which is being held November 14-16, 2023.

  November 7, 2023

   · 

  2 min read
• Business

  ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

  ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to the U.S. financial markets open.

  November 7, 2023

   · 

  1 min read
• Business

  Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023

  Inhibikase Therapeutics, Inc. announced that it will report financial results for the third quarter ended September 30, 2023, on Tuesday, November 14, 2023, after the close of U.S. markets.

  November 7, 2023

   · 

  2 min read
• BioMidwest

  Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November 2023

  Pacira BioSciences, Inc. announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences.

  November 7, 2023

   · 

  1 min read